Literature DB >> 27765562

Extreme lateral interbody fusion (XLIF): A single-center clinical and radiological follow-up study of 20 patients.

Enrico Tessitore1, Granit Molliqaj2, Karl Schaller2, Oliver Pascal Gautschi2.   

Abstract

Extreme lateral interbody fusion (XLIF) is an alternative to standard posterior approaches for achieving fusion in the lumbar spine. It allows exposure of the lateral aspect of the lumbar disc through a lateral approach with the possibility to insert a wide footprint interbody cage as a stand-alone procedure or associated with a uni- or bilateral percutaneous fixation. This is a retrospective series of 20 consecutive patients operated with a XLIF procedure from 2014 to 2015. N=10 women and N=10 men with a mean age of 67.5years (range 37.9-81.2) were included in the study. N=18 patients have been operated at one level, while N=2 patients underwent a double-level XLIF. The index levels were: L2-L3 in 2, L3-L4 in 7, L4-L5 in 9 and L3-L5 in 2 patients, respectively. The mean clinico-radiological follow-up was 9.8months (range 2.5-16.6). The clinical outcome was assessed with the Oswestry Disability Index (ODI), Euro-Qol (EQ)-5D, visual analogue scale (VAS) and EQ-5D index scores. Preoperative, postoperative and follow-up sagittal balance was assessed by EOS full spine X-ray. Furthermore, presence or absence of fusion was assessed by thin cuts CT scan at the end of the follow-up. The analysis highlighted a clear clinical improvement for the study collective. The mean ODI improved from 41.6 preoperatively to 23.5 at the last follow-up (p<0.0036). EQ-5D VAS and EQ-5D index improved from 45.5 to 71.8 (p<0.0001) and from 0.454 to 0.693 (p<0.0002), respectively. Analysis of the sagittal balance revealed an increase of the total lumbar lordosis, however not in a statistically significant manner (p=0.164). Furthermore, an increase of 55.7% in mean disc height (from 7.0mm to 10.9mm) has been observed (p<0.0001). Surprisingly, the right foramen height was increased in a statistically significant manner compared to the left one, but both of them increased in absolute values. However, foraminal area on both sides did not significantly increase. The mean canal area was 115.7mm2 preoperatively and 136.5mm2 at follow-up (p=0.1325). Radiological fusion was observed in every case at the end of the follow-up period. The XLIF procedure accomplishes a secure and effective interbody fusion. This approach allows for an indirect decompression of neural structures by restoring foramen dimensions and disc space height, leading to an improvement of symptoms. Furthermore, XLIF seems to improve segmental sagittal balance.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clinical and radiological follow-up; Directional neuromonitoring; Extreme lateral interbody fusion; Minimal invasive spine surgery; XLIF®

Mesh:

Year:  2016        PMID: 27765562     DOI: 10.1016/j.jocn.2016.10.001

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  14 in total

1.  Three-dimensional computed tomographic evaluation of lateral lumbar interbody fusion: morphometric change of intervertebral structure.

Authors:  Koji Akeda; Kevin Cheng; Edward Abarado; Norihiko Takegami; Junichi Yamada; Nozomu Inoue; Koichi Masuda; Akihiro Sudo
Journal:  Eur Spine J       Date:  2021-03-02       Impact factor: 3.134

Review 2.  Incidence of major and minor vascular injuries during lateral access lumbar interbody fusion procedures: a retrospective comparative study and systematic literature review.

Authors:  Alexander O Aguirre; Mohamed A R Soliman; Shady Azmy; Asham Khan; Patrick K Jowdy; Jeffrey P Mullin; John Pollina
Journal:  Neurosurg Rev       Date:  2021-12-01       Impact factor: 3.042

3.  Lateral lumbar interbody fusion using a cellular allogeneic bone matrix in the treatment of symptomatic degenerative lumbar disc disease and lumbar spinal instability.

Authors:  William C Tally; H Thomas Temple; J Kenneth Burkus
Journal:  J Spine Surg       Date:  2021-09

4.  Quantitative analysis of indirect decompression in extreme lateral interbody fusion and posterior spinal fusion with a percutaneous pedicle screw system for lumbar spinal stenosis.

Authors:  Hiroshi Nomura; Akihisa Yamashita; Tetsuya Watanabe; Kenzo Shirasawa
Journal:  J Spine Surg       Date:  2019-06

Review 5.  Lateral Lumbar Interbody Fusion: What Is the Evidence of Indirect Neural Decompression? A Systematic Review of the Literature.

Authors:  Matteo Formica; Emanuele Quarto; Andrea Zanirato; Lorenzo Mosconi; Davide Vallerga; Irene Zotta; Maddalena Lontaro Baracchini; Carlo Formica; Lamberto Felli
Journal:  HSS J       Date:  2020-03-20

6.  Dynamic Posture-Related Preoperative Pain as a Single Clinical Criterion in Patient Selection for Extreme Lateral Interbody Fusion Without Direct Decompression.

Authors:  Kai-Zheong Lim; Christopher Daly; Jessica Brown; Tony Goldschlager
Journal:  Global Spine J       Date:  2018-11-15

7.  Radiographic and clinical outcome of lateral lumbar interbody fusion for extreme lumbar spinal stenosis of Schizas grade D: a retrospective study.

Authors:  Jun Li; Hao Li; Ning Zhang; Zhi-Wei Wang; Teng-Fei Zhao; Lin-Wei Chen; Gang Chen; Qi-Xin Chen; Fang-Cai Li
Journal:  BMC Musculoskelet Disord       Date:  2020-04-20       Impact factor: 2.362

8.  Differences in radiographic and clinical outcomes of oblique lateral interbody fusion and lateral lumbar interbody fusion for degenerative lumbar disease: a meta-analysis.

Authors:  Hui-Min Li; Ren-Jie Zhang; Cai-Liang Shen
Journal:  BMC Musculoskelet Disord       Date:  2019-12-04       Impact factor: 2.362

9.  Initial multi-centre clinical experience with prone transpsoas lateral interbody fusion: Feasibility, perioperative outcomes, and lessons learned.

Authors:  Tyler G Smith; Samuel A Joseph; Benjamin Ditty; Rodrigo Amaral; Antoine Tohmeh; William R Taylor; Luiz Pimenta
Journal:  N Am Spine Soc J       Date:  2021-03-04

10.  Extreme lateral interbody fusion (XLIF) in a consecutive series of 72 patients.

Authors:  Mirza Pojskic; Benjamin Saβ; Benjamin Völlger; Christopher Nimsky; Barbara Carl
Journal:  Bosn J Basic Med Sci       Date:  2021-10-01       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.